SYNTHESIS, PHARMACOLOGICAL, CONFORMATIONAL, AND DYNAMIC STUDIES OF THE POTENT HORMONE ANTAGONISTS [1‐PENICILLAMINE, 4‐THREONINE]‐OXYTOCIN AND [1‐PENICILLAMINE, 2‐PHENYLALANINE, 4‐THREONINE] ‐OXYTOCIN
- 1 November 1980
- journal article
- research article
- Published by Wiley in International Journal of Peptide and Protein Research
- Vol. 16 (5) , 372-381
- https://doi.org/10.1111/j.1399-3011.1980.tb02961.x
Abstract
The solid phase synthesis of [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin is reported. The 2 compounds have no in vitro milk ejecting activity and no in vivo or in vitro oxytocic activity, but both are potent antagonists in these 3 assay systems. In the in vitro oxytocic assay, [1-penicillamine, 4-threonine]- and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin have pA2 values of 7.55 .+-. 0.04 and 7.67 .+-. 0.02, respectively, and both inhibit the uterine contractile response to oxytocin in nonpregnant and pregnant rats. [1-Penicillamine, 2-phenylalanine, 4-threonine]-oxytocin has a weak antipressor activity and at high doses, consistently caused a weak and transient fall in blood pressure in the rat. Carbon-13 NMR chemical shift parameters and spin-lattice relaxation times (T1) indicate that these 2 new oxytocin antagonists have very similar conformation and dynamic properties to oxytocin inhibitors which were previously examined. These results are discussed in terms of conformational and dynamic models of oxytocin antagonism at the uterus. Conformational restrictions at the 2- and 4-positions of penicillamine-1 analogs of oxytocin may be important to antagonist activity and potency.Keywords
This publication has 22 references indexed in Scilit:
- Synthetic antagonists of in vivo responses by the rat uterus to oxytocinJournal of Medicinal Chemistry, 1979
- Active site studies of neurohypophyseal hormones. Comparison of oxytocin and arginine vasopressin analogs containing 2-D-tyrosineJournal of the American Chemical Society, 1979
- [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitorJournal of Medicinal Chemistry, 1979
- Carbon-13 NMR studies of the Peptide hormones oxytocin, arginine vasopressin, isotocin, mesotocin, glumitocin, aspartocin, related analogs, and diastereoisomers. Use of specifically deuterated hormone derivatives for assignments and effects of structural changes on carbon-13 NMR chemical shifts in peptidesJournal of the American Chemical Society, 1979
- [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocinJournal of Medicinal Chemistry, 1978
- Synthesis of specifically deuterated S-benzylcysteines and of oxytocin and related diastereomers deuterated in the half-cystine positionsThe Journal of Organic Chemistry, 1976
- Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocinJournal of Medicinal Chemistry, 1975
- The Preparation of Merrifield‐Resins Through Total Esterification With Cesium SaltsHelvetica Chimica Acta, 1973
- Partition Chromatography of Oxytocin on ‘Sephadex’Nature, 1964
- Synthesis of a Biologically Active Analog of Oxytocin, with Phenylalanine Replacing Tyrosine1,2Journal of the American Chemical Society, 1959